CDH1 and neoplasm: None of the eight tumours that presented nuclear E-cadherin went through re-intervention or adjuvant intervention, while nine (43%) and four (17%) out of the adenomas not presenting nuclear E-cadherin (N = 21) were in need of re-intervention or adjuvant intervention, respectively.